Relationship between hyperuricemia and other cardiovascular disease risk factors among adult males in Taiwan
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Hyperuricemia is associated with cardiovascular disease risk factors such as obesity, impaired glucose tolerance, hypertension, and hyperlipidemia. However, this relationship between serum uric acid (SUA) concentrations and cardiovascular disease (CVD) is a controversial one, especially among males. The purpose of this study is to evaluate the association between SUA concentrations and other CVD risk factors among adult males in Taiwan. After multi-stage sampling procedures, we randomly selected 1743 Taiwanese males with a mean age of 35 years (from 22 to 54) in this study. Anthropometric, blood pressure and biochemical variables, including serum uric acid, glucose, total cholesterol and triglyceride concentrations, were measured. Among the study population, the mean SUA concentration was 6.5 ± 1.5 mg/dl. There were 290 (16.6%) subjects with SUA concentrations ≥ 8.0 mg/dl (defined as hyperuricemia). Compared to normouricemic subjects, hyperuricemic subjects had significantly greater age-adjusted body weight (75.3 vs. 69.2 kg, p < 0.001), body mass index (BMI, 25.5 vs. 23.6 kg/m2, p < 0.001), higher blood pressure (BP, 120.2 vs. 115.2 mmHg for systolic BP and 78.5 vs. 75.3 mmHg for diastolic BP, both p < 0.001) and blood lipid concentrations (193.8 vs. 182.1 mg/dl for total cholesterol and 123.7 vs. 94.4 mg/dl for triglycerides, both p < 0.001). SUA concentration was positively correlated with body weight, BMI, BP and serum lipid concentrations (all p < 0.001). In multivariate regression analyses, after adjusting for potential confounders, SUA concentration was significantly positively associated with diastolic BP, serum total cholesterol and triglyceride concentrations. An increase of 1 mg/dl of SUA was associated with a 2.1 mg/dl elevation in serum total cholesterol (p < 0.001) and a 5.4 mg/dl increase in triglyceride (p < 0.001). From this study, we found that hyperuricemia in subjects is associated with being overweight, and having high blood pressure and hyperlipidemia. There is a significantly positive association between SUA concentration and other CVD risk factors among adult males in Taiwan.
- Department of Health, The Executive Yuan, ROC. Public Health in Taiwan Area, Republic of China, 1995.
- Department of Health, The Executive Yuan, ROC. The National Nutritional Guide Book (II), 1991.
- Levine W, Dyer AR, Shekelle RB, Schoenberger JAB, Stamler J. Serum uric acid and 11.5-year mortality of middle-aged women: Findings of the Chicago heart association detection project in industry. J Clin Epidemiol 1989; 42: 257–267.
- Freedman DS, Williamson DF, Gunter EW, Byers T. Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I epidemiologic follow-up study. Am J Epidemiol 1995; 141: 637–644.
- Lee J, Sparrow D, Vokonas PS, Landsberg L, Weiss ST. Uric acid and cardiovascular disease risk: Evidence for a role of uric acid in the obesity-insulin resistance syndrome. Am J Epidemiol 1995; 142: 288–294.
- Kotake H, Sawada Y, Hoshio A, Shirota K, Tomokuni A, Doi T, Hisatome I, Mashiba H. Relation between serum uric acid and angiographically defined coronary artery disease in postmenopausal women. J Med 1992; 23: 409–415.
- Fessel WJ. High uric acid as an indicator of cardiovascular disease. Independent from obesity. Am J Med 1980; 68: 401–404.
- Persky VW, Dyer AR, Idris-Soven E, Stamler J, Shekelle RB, Schoenberger JAB, Berkson DM, Lindberg HA. Uric acid: a risk factor for cardiovascular disease? Circulation 1979; 59: 969–977.
- Jacobs D. Hyperuricemia as a risk factor in cardiovascular disease. Adv Exp Med Biol 1977; 76B: 231–237.
- Brand FN, McGee DL, Kannel WB, Stokes III J, Castelli WP. Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study. Am J Epidemiol 1985; 121: 11–18.
- Iribarren C, Sharp DS, Curb JD, Yano K. High uric acid: A metabolic marker of coronary heart disease among alcohol abstainers? J Clin Epidemiol 1996; 49: 673–678.
- Hisatome I, Saitoh M, Ogino K, Miyamoto J, Hoshio A, Ishiko R, Hasegawa J, Kotake H, Mashiba H. Differences in urate metabolism between normouricemia and hyperuricemia in cardiovascular disease in men. J Med 1990; 20: 363–370.
- Wannamethee SG, Shaper AG, Whincup PH. Serum urate and the risk of major coronary heart disease events. Heart 1997; 78: 147–153.
- Liang JK. A clinical study of hyperuricemia men. N Z Med J 1975; 82: 408–410.
- Mustard JF, Murphy EA, Orryzlo MA, et al. Blood coagulation and platelet economy in subjects with primary gout. Can Med Assoc J 1963; 89: 1207–1211.
- Newland H. Hyperuricemia in coronary, cerebral, and peripheral arterial disease: an explanation. Med Hypotheses 1975; 1: 152–155.
- Frolich ED. Uric acid: A risk factor for cardiovascular disease. JAMA 1993; 270: 378–379.
- Messerli FH, Frolich ED, Dreslinski GR, et al. Serum uric acid in essential hypertension: An indicator of renal vascular involvement. Ann Intern Med 1980; 93: 817–821.
- Tweeddale MG, Fodor JG. Elevated serum uric acid. A cardiovascular risk factor? Nephron 1979; 23, Suppl 1: 3–6.
- Criqui MH, Barrett-Connor E, Holdbrook MJ, Austin M, Turner JD. Clustering of cardiovascular disease risk factors. Prev Med 1980; 9: 525–533.
- Kannel WB, Wilson PWF. An update on coronary risk factors. Med Clin North Am 1995; 79: 951–971.
- Bonora E, Targher G, Zenere MB, Saggiani F, Cacciatori V, Tosi F, Travia D, Zenti MG, Branzi P, Santi L, Muggeo M. Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int J Obes 1996; 20: 975–980.
- Kadish AH, Litle RL, Sternberg JC. A new and rapid method for determination of glucose by measurement of rate of oxygen consumption. Clin Chem 1968; 14: 116–131.
- Leon LP, Chu DK, Stasiw RP, et al. New, more specific methods for the SMA 12/60 multichannel biochemical analyzer. In: Advances in automated analysis. (Proceedings of the Technicon International Congress, 1976). Vol 1. Tarrytown, NY: Mediad, Inc., 1977: 152–156.
- Richmond W. Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem 1973; 19: 1350–1356.
- Stavropoulos WS, Crouch RD. A new colorimetric procedure for the determination of serum triglyceride. Clin Chem 1974; 20: 857.
- Okada M, Ueda K, Omae T, Takeshita M, Hirota Y. The relationship of serum uric acid to hypertension and ischemic heart disease in Hisayama population, Japan. J Chron Dis 1982; 35: 173–178.
- Reunanen A, Takkunen H, Knekt P, Aromaa A. Hyperuricemia as a risk factor for cardiovascular mortality. Acta Med Scand 1982; 668 Suppl: 49–59.
- Iribarren C, Folsom AR, Eckfeldt JH, McGovern PG, Nieto FJ. Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: The ARIC Study. Ann Epidemiol 1996; 6: 331–340.
- Yu T, Talbott JH. Changing trends of mortality in gout. Seminars Arth Rheum 1980; 10: 1–9.
- Cook DG, Sharper AG, Thelle DS, Whitehead TP. Serum uric acid, serum glucose and diabetes: relationships in a population study. Postgrad Med J 1986; 1001–1006.
- Relationship between hyperuricemia and other cardiovascular disease risk factors among adult males in Taiwan
European Journal of Epidemiology
Volume 16, Issue 1 , pp 13-17
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers
- Additional Links
- Cardiovascular disease
- Risk factors
- Taiwanese males
- Industry Sectors
- Author Affiliations
- 1. Department of Public Health, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC
- 2. Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC